Zentalis Pharmaceuticals (ZNTL)
By Fri, Oct 15, 2021
Today’s Chart of the Week comes from our 2 to 100 Club Report.
This scanner specifically looks for small to midcap stocks poised to become the next $100 billion company.
And when it comes to that, pharmaceuticals are always a good place to look.
That’s why we’re long on Zentalis Pharmaceuticals (ZNTL).
Zentalis is a midcap stock valued around $6 billion that is poised for a nice gain.
There’s a major base we’ve broken out of, and as I like to say, the “bigger the base, the higher in space.”
There’s a nice uptrend here, with a phenomenal risk to reward ratio.
We are long ZNTL above 80 with a target of 113.
Til next week, good trading,
JC Parets
Sponsored Ad
Free Training: 60-Minutes to Trading Freedom
Would you like to make more money in one hour of fun trading than working all day at a job?
Then check this out…
About the Author
JC Parets, founder of All Star Charts, specializes in finding the most opportunistic risk vs. reward propositions while at the same time bringing a top/down approach to the marketplace whose wide spectrum is rivaled by few. JC begins with a long-term global macro perspective and then works his way down to the individual sector and industry level before ultimately isolating the stocks that best portray a particular thesis. Price is the most important technical indicator, but JC uses supplements such as Momentum, Relative Strength, and Fibonacci analysis to complete the process.
